08/07/2025
7:42 AM | Akebia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2025
6:38 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2025
6:06 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
4:46 PM | Akebia Therapeutics (Subject)
Ostrowski Erik (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2025
6:21 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
4:13 PM | Akebia Therapeutics (Issuer)
Malabre Richard C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:13 PM | Akebia Therapeutics (Issuer)
FRIESON RON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:14 PM | Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:14 PM | Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:15 PM | Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:15 PM | Akebia Therapeutics (Issuer)
Wolf Myles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AKBA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Akebia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/11/2025
4:16 PM | ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:16 PM | Akebia Therapeutics (Issuer)
ZUMWALT LEANNE M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
6:04 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:29 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/20/2025
3:44 PM | Akebia Therapeutics (Filer)
| Form 424B5 | |
03/20/2025
3:48 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2025
3:12 PM | Akebia Therapeutics (Filer)
| Form 424B5 | |
03/13/2025
6:27 AM | Akebia Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2025
6:08 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
4:05 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
4:39 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
4:37 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2025
7:16 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
4:48 PM | Akebia Therapeutics (Issuer)
Ostrowski Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:51 PM | Akebia Therapeutics (Issuer)
Grund Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:52 PM | Akebia Therapeutics (Issuer)
Malabre Richard C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:53 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:54 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:50 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
4:58 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
5:02 PM | Akebia Therapeutics (Subject)
Grund Nicholas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
6:40 AM | Akebia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/13/2025
7:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:16 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/22/2024
5:06 PM | Akebia Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/22/2024
7:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
6:36 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
11:15 PM | Akebia Therapeutics (Filer)
| Form EFFECT | |
08/08/2024
6:52 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
08/08/2024
6:06 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
